The effect of phenformin plus stanozolol on fibrinolysis, platelet adhesiveness and blood lipids in patients with recurrent venous thrombosis.
D000328:Adult; D000368:Aged; D002784:Cholesterol / Q000097:blood; D004359:Drug Therapy, Combination; D004492:Edetic Acid; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D008297:Male; D008875:Middle Aged; D010629:Phenformin / Q000627:therapeutic use*; D010973:Platelet Adhesiveness / Q000187:drug effects*; D012008:Recurrence; D012712:Serum Globulins; D013197:Stanozolol / Q000627:therapeutic use*; D013924:Thrombophlebitis / Q000188:drug therapy*
D008055:Lipids; D008074:Lipoproteins; D012712:Serum Globulins; D013197:Stanozolol; D005340:Fibrinogen; D002784:Cholesterol; D004492:Edetic Acid; D010629:Phenformin